(Date:5/10/2008)...on Continues with Efforts to Gain Clearance for Ai...es, STAMFORD, Conn., May 10 /PRNewswire-USNewswir...d in Myanmar earlier today to assess the,crisis si...nce for the,organization,s airlift of 15 tons of e..., "AmeriCares is working closely with the World H...
(Date:5/10/2008)..., May 10 /PRNewswire/ -- Children,s Hospital of Pi...g its new state-of-the-art hospital,campus., (Pho...NESA001 ), When the new Children,s Hospital open...ric care nationwide. The new hospital building wil...lopment project that is,situated on a 10-acre camp...
(Date:5/9/2008)...lif., May 9 /PRNewswire-FirstCall/ -- AMDL, Inc. (...ed specialty pharmaceutical company,with operation...de,Pharmaceutical Inc., today announced that its c...d December 31, 2007, which were included in its,An... and Exchange,Commission on April 14, 2008, contai...
(Date:5/9/2008)...lar whole grain may provide protection against hea...ncers, ARLINGTON, Va., May 8 /PRNewswire/ -- Brow...recognized ranks of healthful whole grains, accord...d and Drug Administration,(FDA) that will allow br...h,claim. This will enable consumers to easily iden...
Breaking Medicine News(10 mins):Health News:AmeriCares Relief Worker Arrives in Myanmar 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 2Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 3Health News:ONE YEAR Until the New Children's Hospital of Pittsburgh of UPMC Opens in Lawrenceville 4Health News:AMDL Reports Going Concern Qualification 2Health News:FDA Approves Health Claim for Brown Rice 2Health News:FDA Approves Health Claim for Brown Rice 3Health News:FDA Approves Health Claim for Brown Rice 4Health News:FDA Approves Health Claim for Brown Rice 5(Date:5/9/2008)... BANGKOK, Thailand, May 9 /PRNewswire-USNewswire/...ciety for the Protection of Animals (WSPA),is on s...clone struck,Myanmar to assess and then relieve th...vivors depend on for food and their livelihoods.,...nd Agriculture,Organization of the United Nations ...
(Date:5/9/2008)... SAN DIEGO, May 9 /- Ardea...used on the discovery and development of,small- mo...er and,inflammatory diseases, including gout, toda...enior Vice President, Finance and Operations and C...will resign from our board of,directors shortly th...
(Date:5/8/2008)... MIAMI, May 8 /- Globus Medical, Inc...acturer in the world and a recognized,leader in mo...completion of,enrollment in its SECURE(R)-C Cervic...ce is designed to mimic the normal motion of the s...on as an alternative to fusion in,the treatment of...
(Date:5/8/2008)... DEERFIELD, Ill., May 8 /-...America(R) Holdings (LabCorp(R)) today announced,t... discuss future,possibilities to co-develop new cl...diagnostics, metabolic syndrome, oncology and diab...l focus on developing new tests that,could make th...
Breaking Medicine Technology:Animals That Cyclone Survivors Depend on Need Help Now 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB 403 for the Treatment of Cancer 2648 1ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB 403 for the Treatment of Cancer 2648 2ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB 403 for the Treatment of Cancer 2648 3ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB 403 for the Treatment of Cancer 2648 4ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB 403 for the Treatment of Cancer 2648 5Parker Waichman Alonso LLP Becnel Law Firm LLC Douglas 26 London P C Levin 9746 1Web Hosted Attendance on Demand 28R 29 Introduces Innovative Web Time Clock 1948 1Web Hosted Attendance on Demand 28R 29 Introduces Innovative Web Time Clock 1948 2Nonlinear ecosystem response points to environmental solutions 1946 1Nonlinear ecosystem response points to environmental solutions 1946 2Nonlinear ecosystem response points to environmental solutions 1946 3...oms and urine flow over 28-week period, QUEBEC CIT...entaris Inc. , a global biopharmaceutical company ...nnounced that its partner,Spectrum Pharmaceuticals...results for AEterna Zentaris, fourth-generation lu...tagonist, ozarelix, in,benign prostatic hyperplasi...
...07-The chemotherapy drug,docetaxel currently offer...tate cancer. That is the result of a now,published...two most,widely used chemotherapy drugs. When usin...ut by more than 50% than when using the,next-best ...eat prostate cancer has rapidly,grown in importanc...
Other Medicine Technology:AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 2AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 3AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 4AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 5Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy 2Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of,Docetaxel Chemotherapy 3... technology, the wire crosses the lesion first, in... other actions, including filter placement and ret...hen occur over the wire., ,Emboshield is desig...carotid stenting procedure, and it is the only fil...
...ip product, the Super Premium ALPHA 10 System offe...atility in an intuitive and ergonomically designed...or Perinatology/Maternal & Fetal Medicine Speciali...Breast Imaging, and General Imaging departments in...
...tra Laboratory has been uniquely designed to fit t...ks spanning multi-facilities. From test initiation...ts receivable, Centricity Ultra facilitates quick,...system modules are fully integrated and reside und...
CELL-DYN Sapphire, our flagship solution for high-volume laboratories, utilizes patented MAPSS plus 3-color fluorescent technology for improved lab efficiency.
Medicine Products: